Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit

Detalles Bibliográficos
Autores principales: Quaglino, Pietro, Fava, Paolo, Brizio, Matteo, Marra, Elena, Rubatto, Marco, Merli, Martina, Tonella, Luca, Ribero, Simone, Fierro, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874884/
https://www.ncbi.nlm.nih.gov/pubmed/33533662
http://dx.doi.org/10.2217/fon-2020-0997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874884/
https://www.ncbi.nlm.nih.gov/pubmed/33533662
http://dx.doi.org/10.2217/fon-2020-0997

Ejemplares similares